136 related articles for article (PubMed ID: 38097064)
1. Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis.
Tanaka M; Kaji K; Nishimura N; Asada S; Koizumi A; Matsuda T; Yorioka N; Tsuji Y; Fujinaga Y; Sato S; Namisaki T; Akahane T; Yoshiji H
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119649. PubMed ID: 38097064
[TBL] [Abstract][Full Text] [Related]
2. Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.
Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
Dig Dis Sci; 2016 Nov; 61(11):3190-3198. PubMed ID: 27572941
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin Receptor Blockers Potentiate the Protective Effect of Branched-Chain Amino Acids on Skeletal Muscle Atrophy in Cirrhotic Rats.
Takeda S; Kaji K; Nishimura N; Enomoto M; Fujimoto Y; Murata K; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
Mol Nutr Food Res; 2021 Dec; 65(24):e2100526. PubMed ID: 34687151
[TBL] [Abstract][Full Text] [Related]
4. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia.
Burks TN; Andres-Mateos E; Marx R; Mejias R; Van Erp C; Simmers JL; Walston JD; Ward CW; Cohn RD
Sci Transl Med; 2011 May; 3(82):82ra37. PubMed ID: 21562229
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice.
Iwai S; Kaji K; Nishimura N; Kubo T; Tomooka F; Shibamoto A; Suzuki J; Tsuji Y; Fujinaga Y; Kitagawa K; Namisaki T; Akahane T; Yoshiji H
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166770. PubMed ID: 37276988
[TBL] [Abstract][Full Text] [Related]
6. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
Fujinaga Y; Kawaratani H; Kaya D; Tsuji Y; Ozutsumi T; Furukawa M; Kitagawa K; Sato S; Nishimura N; Sawada Y; Takaya H; Kaji K; Shimozato N; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759852
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis.
Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H
Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis.
Namisaki T; Noguchi R; Moriya K; Kitade M; Aihara Y; Douhara A; Nishimura N; Takeda K; Okura Y; Kawaratani H; Takaya H; Seki K; Yoshiji H
J Gastroenterol; 2016 Feb; 51(2):162-72. PubMed ID: 26190501
[TBL] [Abstract][Full Text] [Related]
10. Magnoliae Cortex Alleviates Muscle Wasting by Modulating M2 Macrophages in a Cisplatin-Induced Sarcopenia Mouse Model.
Hong M; Han IH; Choi I; Cha N; Kim W; Kim SK; Bae H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804803
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle atrophy is exacerbated by steatotic and fibrotic liver-derived TNF-α in senescence-accelerated mice.
Shirakami Y; Kato J; Maeda T; Ideta T; Imai K; Sakai H; Shiraki M; Shimizu M
J Gastroenterol Hepatol; 2023 May; 38(5):800-808. PubMed ID: 36890117
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
13.
Yang L; Jiang X; Fu S; Tan J; Dian W; Zhou Y
Discov Med; 2024 Feb; 36(181):402-414. PubMed ID: 38409845
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia.
Kingsley J; Torimoto K; Hashimoto T; Eguchi S
Clin Sci (Lond); 2021 Nov; 135(21):2503-2520. PubMed ID: 34751393
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions.
Warner Ii ER; Satapathy SK
J Clin Exp Hepatol; 2023; 13(1):162-177. PubMed ID: 36647414
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
18. SIRT1-dependent mechanisms and effects of resveratrol for amelioration of muscle wasting in NASH mice.
Liu CW; Huang CC; Hsu CF; Li TH; Tsai YL; Lin MW; Tsai HC; Huang SF; Yang YY; Hsieh YC; Lee TY; Tsai CY; Huang YH; Hou MC; Lin HC
BMJ Open Gastroenterol; 2020 May; 7(1):. PubMed ID: 32371503
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy.
Yoshida T; Delafontaine P
Cells; 2020 Aug; 9(9):. PubMed ID: 32858949
[TBL] [Abstract][Full Text] [Related]
20. Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice.
Sakai H; Asami M; Naito H; Kitora S; Suzuki Y; Miyauchi Y; Tachinooka R; Yoshida S; Kon R; Ikarashi N; Chiba Y; Kamei J
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1570-1581. PubMed ID: 34268902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
